Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2025 Jan 23;16(3):358-360.
doi: 10.1021/acsmedchemlett.5c00013. eCollection 2025 Mar 13.

Hydroquinazoline Derivatives as Novel Natriuretic Peptide Receptor 1 (NPR1) Activators

Xin Zhou  1 , Steven H Liang  1
Affiliations
Editorial

Hydroquinazoline Derivatives as Novel Natriuretic Peptide Receptor 1 (NPR1) Activators

Xin Zhou et al. ACS Med Chem Lett. .

Abstract

This patent highlights hydroquinazoline compounds and their pharmaceutically acceptable salts, as well as compositions and methods of preparation. The compounds in this invention were evaluated for their potency on Natriuretic Peptide Receptor 1 (NPR1), a receptor guanylate cyclase known to play a critical role in lowering blood pressure and blood volume.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing financial interest.

Similar articles

See all similar articles

References

    1. Giovou A. E.; Gladka M. M.; Christoffels V. M. The Impact of Natriuretic Peptides on Heart Development, Homeostasis, and Disease. Cells 2024, 13 (11), 931.10.3390/cells13110931. - DOI - PMC - PubMed
    1. Dickinson Y. A.; Moyes A. J.; Hobbs A. J. C-type natriuretic peptide (CNP): The cardiovascular system and beyond. Pharmacol Ther 2024, 262, 108708.10.1016/j.pharmthera.2024.108708. - DOI - PubMed
    1. Haghighat L.; DeJong C.; Teerlink J. R. New and future heart failure drugs. Nat. Cardiovasc Res. 2024, 3 (12), 1389–1407. 10.1038/s44161-024-00576-z. - DOI - PubMed
    1. Mishra S.; Chander V.; Kass D. A. Cardiac cGMP Regulation and Therapeutic Applications. Hypertension 2025, 82, 185–196. 10.1161/HYPERTENSIONAHA.124.21709. - DOI - PMC - PubMed
    1. De la Sierra A.; Oliveras A. New therapeutic targets in hypertension. Medicina Clínica (English Edition) 2024, 163 (6), 301–305. 10.1016/j.medcle.2024.03.025. - DOI - PubMed

Publication types

LinkOut - more resources